|Solubility:||DMSO up to 20 mM|
|Chemical Name:||2-(((1R,2S)-2-(4-(benzyloxy)phenyl)cyclopropyl)amino)-1-(4-methylpiperazin-1-yl)ethanone HCl salt|
|Storage:||Powder: 4oC 1 year. DMSO: 4oC 3 month; -20oC 1 year.|
RN-1 is a potent, specific and brain-penetrant Lysine Specific Demethylase-1 (LSD1) inhibitor. It inhibits LSD1 in biochemical assay with an IC50 ~70 nM, and has weaker activity against monoamine oxidase proteins MAO-A and MAO-B with IC50 ~0.51 µM and 2.79 µM respectively. It exhibits good brain penetration and retention following systemic administration. RN-1 can abolish long-term memory formation without affecting short-term memory in the novel object recognition (NOR) mouse model. RN-1 could be a useful chemical probe to study the importance of reversible histone methylation in the function of the nervous system.
How to Use:
- In vitro: RN-1 was used at 1 µM in vitro.
- In vivo: RN-1 was administered by intraperitoneal injection once a day at a dose of 10-30 mg/kg to the novel object recognition (NOR) mouse model. RN-1 exhibits good brain penetration and retention.
- Neelamegam R, et al. Brain-penetrant LSD1 inhibitors can block memory consolidation. (2012) ACS Chem Neurosci. 3(2):120-128.
Products are for research use only. Not for human use.